United States · Bill · HR
H.R. 1798 (106th)
Clinical Research Enhancement Act of 1999
Introduced
13 May 1999
Last action
25 October 2000 · Reported
Status
Placed on the Union Calendar, Calendar No. 585.
Sponsors
Rep. Greenwood, James C. [R-PA-8], Rep. Lowey, Nita M. [D-NY-17], Rep. Johnson, Nancy L. [R-CT-5], Sen. Brown, Sherrod [D-OH], Sen. Burr, Richard [R-NC], Rep. Waxman, Henry A. [D-CA-33], Rep. Pickering, Charles W. "Chip" [R-MS-3], Rep. Deal, Nathan [R-GA-9], Rep. Morella, Constance A. [R-MD-8], Rep. Frank, Barney [D-MA-4], Rep. DeLauro, Rosa L. [D-CT-3], Rep. Nethercutt, George R., Jr. [R-WA-5], Rep. Leach, James A. [R-IA-2], Rep. English, Phil [R-PA-3], Rep. Towns, Edolphus [D-NY-10], Rep. Coyne, William J. [D-PA-14], Rep. Lewis, John [D-GA-5], Rep. Nadler, Jerrold [D-NY-12], Sen. Wicker, Roger F. [R-MS], Rep. Filner, Bob [D-CA-51], Rep. Pelosi, Nancy [D-CA-11], Rep. Slaughter, Louise McIntosh [D-NY-25], Rep. Capuano, Michael E. [D-MA-8], Rep. McGovern, James P. [D-MA-2], Rep. Frost, Martin [D-TX-24], Rep. Upton, Fred [R-MI-6], Rep. Wynn, Albert Russell [D-MD-4], Rep. Hoyer, Steny H. [D-MD-5], Rep. McNulty, Michael R. [D-NY-23], Rep. Gonzalez, Charles A. [D-TX-20], Rep. Sandlin, Max [D-TX-1], Rep. Norwood, Charles W. [R-GA-9], Rep. Deutsch, Peter [D-FL-20], Rep. Eshoo, Anna G. [D-CA-18], Rep. Thurman, Karen L. [D-FL-5], Rep. Barrett, Thomas M. [D-WI-5], Rep. Ehrlich, Robert L., Jr. [R-MD-2], Rep. Price, David E. [D-NC-4], Rep. Martinez, Matthew G. [D-CA-31], Rep. Maloney, Carolyn B. [D-NY-12], Rep. Dixon, Julian C. [D-CA-32], Sen. Stabenow, Debbie [D-MI], Rep. Bilbray, Brian P. [R-CA-50], Sen. Markey, Edward J. [D-MA], Rep. DeGette, Diana [D-CO-1], Sen. Sanders, Bernard [I-VT], Rep. Stark, Fortney Pete [D-CA-13], Rep. Gordon, Bart [D-TN-6]
Subjects
Healthcare, Transport
Source updated
3 June 2026
Summary
Clinical Research Enhancement Act of 1999 - Amends the Public Health Service Act to require the Director of the National Institutes of Health (NIH) to: (1) support and expand the NIH's involvement in clinical research; (2) support and expand the resources available for the clinical research community; and (3) establish peer review mechanisms. (Sec. 4) Mandates grants to: (1) establish general clinical research centers to provide the infrastructure for clinical research, including clinical research training and career enhancement; (2) support individual careers in clinical research at general clinical research centers or other institutions (to be known as Mentor Patient-Oriented Research Career Development Awards); (3) support individual clinical research projects at general clinical research centers or other institutions (to be known as Mid-Career Investigator Awards in Patient-Oriented Research); and (4) support individuals pursuing master's or doctoral degrees in clinical investigation (to be known as graduate training in clinical investigation awards). Authorizes appropriations. (Sec. 5) Increases the limit on the aggregate number of scholarship (regarding professions needed by the NIH) and loan repayment (regarding clinical researchers from disadvantaged backgrounds) contracts under specified provisions. Modifies the loan repayment program to: (1) remove current references to disadvantaged backgrounds; and (2) require a period of service in a general clinical research center, in clinical NIH research, or as a physician receiving a clinical research career enhancement award or a graduate training in clinical investigation award (currently, a period of service as an NIH employee). Requires that at least 50 percent of the loan repayment contracts involve individuals from disadvantaged backgrounds. Authorizes appropriations to carry out the loan repayment provisions. (Sec. 7) Directs the Comptroller General to report to Congress on the extent to which the NIH has complied with requirements of this Act.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
13 May 1999
Introduced
Referred to the House Committee on Commerce.
Source: IntroReferral
13 May 1999
Introduced
Introduced in House
Source: IntroReferral
13 May 1999
Introduced
Introduced in House
Source: IntroReferral
17 May 1999
Introduced
Sponsor introductory remarks on measure. (CR E983)
Source: IntroReferral
25 May 1999
Referred
Referred to the Subcommittee on Health and Environment.
Source: Committee
26 September 2000
Reported
Ordered to be Reported by Voice Vote.
Source: Committee
26 September 2000
Committee
Committee Consideration and Mark-up Session Held.
Source: Committee
26 September 2000
Committee
Subcommittee on Health and Environment Discharged.
Source: Committee
25 October 2000
Calendars
Placed on the Union Calendar, Calendar No. 585.
Source: Calendars
25 October 2000
Reported
Reported by the Committee on Commerce. H. Rept. 106-1002.
Source: Committee
25 October 2000
Reported
Reported by the Committee on Commerce. H. Rept. 106-1002.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Reported in House · 25 October 2000 · Download file
- Introduced in House · 13 May 1999 · Download file
Documents
5 official files
Reported in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Reported in House (text)
Reported in House · EN · 25 October 2000
Reported in House (PDF)
Reported in House · EN · 25 October 2000
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 13 May 1999
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (PDF)
Introduced in House · EN · 13 May 1999
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 13 May 1999
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Greenwood, James C. [R-PA-8] · R · Sponsor
- Rep. Lowey, Nita M. [D-NY-17] · D · Sponsor
- Rep. Johnson, Nancy L. [R-CT-5] · R · Sponsor
- Sen. Brown, Sherrod [D-OH] · D · Sponsor
- Sen. Burr, Richard [R-NC] · R · Sponsor
- Rep. Waxman, Henry A. [D-CA-33] · D · Sponsor
- Rep. Pickering, Charles W. "Chip" [R-MS-3] · R · Sponsor
- Rep. Deal, Nathan [R-GA-9] · R · Sponsor
- Rep. Morella, Constance A. [R-MD-8] · R · Sponsor
- Rep. Frank, Barney [D-MA-4] · D · Sponsor
- Rep. DeLauro, Rosa L. [D-CT-3] · D · Sponsor
- Rep. Nethercutt, George R., Jr. [R-WA-5] · R · Sponsor
- Rep. Leach, James A. [R-IA-2] · R · Sponsor
- Rep. English, Phil [R-PA-3] · R · Sponsor
- Rep. Towns, Edolphus [D-NY-10] · D · Sponsor
- Rep. Coyne, William J. [D-PA-14] · D · Sponsor
- Rep. Lewis, John [D-GA-5] · D · Sponsor
- Rep. Nadler, Jerrold [D-NY-12] · D · Sponsor
- Sen. Wicker, Roger F. [R-MS] · R · Sponsor
- Rep. Filner, Bob [D-CA-51] · D · Sponsor
- Rep. Pelosi, Nancy [D-CA-11] · D · Sponsor
- Rep. Slaughter, Louise McIntosh [D-NY-25] · D · Cosponsor
- Rep. Capuano, Michael E. [D-MA-8] · D · Cosponsor
- Rep. McGovern, James P. [D-MA-2] · D · Cosponsor
- Rep. Frost, Martin [D-TX-24] · D · Cosponsor
- Rep. Upton, Fred [R-MI-6] · R · Cosponsor
- Rep. Wynn, Albert Russell [D-MD-4] · D · Cosponsor
- Rep. Hoyer, Steny H. [D-MD-5] · D · Cosponsor
- Rep. McNulty, Michael R. [D-NY-23] · D · Cosponsor
- Rep. Gonzalez, Charles A. [D-TX-20] · D · Cosponsor
- Rep. Sandlin, Max [D-TX-1] · D · Cosponsor
- Rep. Norwood, Charles W. [R-GA-9] · R · Cosponsor
- Rep. Deutsch, Peter [D-FL-20] · D · Cosponsor
- Rep. Eshoo, Anna G. [D-CA-18] · D · Cosponsor
- Rep. Thurman, Karen L. [D-FL-5] · D · Cosponsor
- Rep. Barrett, Thomas M. [D-WI-5] · D · Cosponsor
- Rep. Ehrlich, Robert L., Jr. [R-MD-2] · R · Cosponsor
- Rep. Price, David E. [D-NC-4] · D · Cosponsor
- Rep. Martinez, Matthew G. [D-CA-31] · D · Cosponsor
- Rep. Maloney, Carolyn B. [D-NY-12] · D · Cosponsor
- Rep. Dixon, Julian C. [D-CA-32] · D · Cosponsor
- Sen. Stabenow, Debbie [D-MI] · D · Cosponsor
- Rep. Bilbray, Brian P. [R-CA-50] · R · Cosponsor
- Sen. Markey, Edward J. [D-MA] · D · Cosponsor
- Rep. DeGette, Diana [D-CO-1] · D · Cosponsor
- Sen. Sanders, Bernard [I-VT] · I · Cosponsor
- Rep. Stark, Fortney Pete [D-CA-13] · D · Cosponsor
- Rep. Gordon, Bart [D-TN-6] · D · Cosponsor
Showing 48 of 54 sponsors and actors.
Related records
- related to ← Clinical Research Enhancement Act of 1999
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/106th-congress/house-bill/1798
- Open data entity: https://api.congress.gov/v3/bill/106/hr/1798
- us · 106-hr-1798 · source updated 3 June 2026